Evidence map›Paper›PMID 25480296›Full record

ArticleCell2014

Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment.

Yonit Lavin, Deborah Winter, Ronnie Blecher-Gonen, Eyal David, Hadas Keren-Shaul, Miriam Merad, Steffen Jung, Ido Amit

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,274 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,274citing papers in PubMed, 3 pooled it
65.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,274 citing papers in PubMed, 3 syntheses or guidelines pooled it, 2,112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Macrophage heterogeneity in human secondary lymphoid organs.Clinical science (London, England : 1979) · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

1,214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yonit LavinDepartment of Oncological Sciences, Immunology Institute and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Deborah WinterDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Ronnie Blecher-GonenDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Eyal DavidDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Hadas Keren-ShaulDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Miriam MeradDepartment of Oncological Sciences, Immunology Institute and the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: miriam.merad@mssm.edu.
Steffen JungDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: s.jung@weizmann.ac.il.
Ido AmitDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: ido.amit@weizmann.ac.il.
Weizmann Institute of Science · ILIcahn School of Medicine at Mount Sinai · USTisch Hospital · US

Funding

Center for Cell CircuitsP50HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2011 to 2015
$15.6M
ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
Post-transcriptional regulation of the Dendritic Cell transcriptomeR01AI104848 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BROWN, BRIAN D, MERAD, MIRIAM · 2013 to 2017
$2.3M
Contribution of the cutaneous APC network to melanoma progression and therapy.R01CA173861 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2013 to 2017
$2.1M
Role of Mucosal DC Subsets in the Control of Influenza A Virus ImmunityU01AI095611 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM, PALUCKA, ANNA KAROLINA · 2011 to 2015
$1.8M
European Research Council 340345NCI NIH HHS NIH R01CA154947ANCI NIH HHS NIHR01CA173861NCI NIH HHS R01 CA154947NCI NIH HHS R01 CA173861NHGRI NIH HHS P50 HG006193NIAID NIH HHS NIHR01AI104848NIAID NIH HHS NIHU01AI095611NIAID NIH HHS R01 AI104848NIAID NIH HHS U01 AI095611PHS HHS NHGRI 1P50HG006193
6 · The paper itself

Abstract

Macrophages are critical for innate immune defense and also control organ homeostasis in a tissue-specific manner. They provide a fitting model to study the impact of ontogeny and microenvironment on chromatin state and whether chromatin modifications contribute to macrophage identity. Here, we profile the dynamics of four histone modifications across seven tissue-resident macrophage populations. We identify 12,743 macrophage-specific enhancers and establish that tissue-resident macrophages have distinct enhancer landscapes beyond what can be explained by developmental origin. Combining our enhancer catalog with gene expression profiles and open chromatin regions, we show that a combination of tissue- and lineage-specific transcription factors form the regulatory networks controlling chromatin specification in tissue-resident macrophages. The environment is capable of shaping the chromatin landscape of transplanted bone marrow precursors, and even differentiated macrophages can be reprogrammed when transferred into a new microenvironment. These results provide a comprehensive view of macrophage regulatory landscape and highlight the importance of the microenvironment, along with pioneer factors in orchestrating identity and plasticity.

Indexed as

Enhancer Elements, GeneticEpigenesis, GeneticAnimalsChromatinFemaleHistone CodeHistonesMacrophagesMice, Inbred C57BLMonocytesOrgan SpecificitySequence Analysis, RNATranscription FactorsTranscriptomeChromatinHistonesTranscription Factors

Identifiers

PMID25480296
PMCPMC4437213
OpenAlexW2126811287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.